Gland Pharma Ltd. NSE: GLAND | BSE: 543245

Mid-range Performer

In 1 Starfolio Basket

Download real time

1680.60 -14.20 (-0.84%)

31.52% Gain from 52W Low

98,422

NSE+BSE Volume

High vol. this week

NSE 09 Jan, 2026 3:31 PM (IST)

US FDA Approval

Gland Pharma gets US FDA nod for Olopatadine Hydrochloride Solution, with a market size of $51 mn See details

Gland Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Gland Pharma from all sources in a single place.

VOTE: Is Gland Pharma Ltd. worth buying?

215 Votes:

Buy 80.93%

Sell 9.3%

Hold 9.77%

RESEARCH REPORTS

Hold SEE REPORTS >

Buy SEE REPORTS >